Evidence map›Paper›PMID 26748807›Full record

ReviewWorld journal of microbiology & biotechnology2016

α-1,3-Glucanase: present situation and prospect of research.

Wasana Suyotha, Shigekazu Yano, Mamoru Wakayama

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. The Significance ofMicroorganisms · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Wasana SuyothaDepartment of Industrial Biotechnology, Faculty of Agro-industry, Prince of Songkla University, Hat Yai, 90112, Thailand.
Shigekazu YanoDepartment of Biochemical Engineering, Graduate School of Sciences and Engineering, Yamagata University, Jonan, Yonezawa, Yamagata, 992-8510, Japan.
Mamoru WakayamaDepartment of Biotechnology, Faculty of Life Sciences, Ritsumeikan University, Kusatsu, Shiga, 525-8577, Japan. wakayama@sk.ritsumei.ac.jp.
Prince of Songkla University · THRitsumeikan University · JPYamagata University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

α-1,3-Glucanases hydrolyze α-1,3-glucan which is an insoluble linear α-1,3-linked homopolymer of glucose and these enzymes are classified into two families of glycoside hydrolases on the basis of amino acid sequence similarity; type-71 α-1,3-glucanases found in fungi and type-87 enzymes in bacteria. α-1,3-Glucan (also called 'mutan') is a major component of dental plaque formed by oral Streptococci and has important physiological roles in various fungal species, including as a component of cell walls, an endogenous carbon source for sexual development, and a virulent factor. Considering these backgrounds, α-1,3-glucanases have been investigated from the perspectives of applications to dental care and development of cell-wall lytic enzymes. Compared with information regarding other glycoside hydrolases such as amylases, cellulases, chitinases, and β-glucanases, there is limited biochemical and structural information available regarding α-1,3-glucanase. Further research on α-1,3-glucanases on enzyme application to dental care and biological control of pathogenic fungi is expected. In this mini-review, we briefly describe how α-1,3-glucanases are categorized and characterized and present our study findings regarding α-1,3-glucanase from Bacillus circulans KA-304. Furthermore, we briefly discuss potential future applications of α-1,3-glucanases.

Indexed as

Amino Acid SequenceBacillusBacteriaCell WallFungiGlycoside HydrolasesHydrolysisMutationPhylogenyexo-1,3-alpha-glucanaseGlycoside HydrolasesFungal cell wallMutanProtoplastα-1,3-Glucanα-1,3-Glucanaseα-1,3-Glucan-binding domains

Identifiers

PMID26748807
OpenAlexW2269949192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.